Source: Annual Congress 2012 - Physiology, heart failure and respiration in relation to OSA
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
J. Ben Amar, L. El Gharbi, B. Dhahri, M.A. Baccar, S. Azzabi, H. Aouina, H. Bouacha (Tunis, Tunisia). Risk factors of hypercapnia in patient with obstructive sleep apnea. Eur Respir J 2012; 40: Suppl. 56, 887

Member's Comments

No comment yet.

Related content which might interest you: The factors related to the daytime hypercapnia in obstructive sleep apnea syndrome Source: Annual Congress 2009 - Control of breathing and respiratory disorders during sleep Year: 2009 Predictors of hypercapnia in obstructive sleep apnoea (OSA) Source: Annual Congress 2010 - Lung disease and mountain sickness: the importance of ventilatory control Year: 2010 Investigation of various factors in obstructive sleep apnea syndrome patients Source: Eur Respir J 2006; 28: Suppl. 50, 194s Year: 2006 Cardiovascular risk factors and the metabolic syndrome in patients with obstructive sleep apnea Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea Year: 2008 Prevalance of daytime hypercapnia in patients with obstructive sleep apnoea syndrome Source: Eur Respir J 2002; 20: Suppl. 38, 574s Year: 2002 Determinants of hypercapnia in obese obstructive sleep apnea (OSA) patients Source: Eur Respir J 2004; 24: Suppl. 48, 447s Year: 2004 Cardiovascular morbidity in obstructive sleep apnoea Source: Annual Congress 2009 - PG5 Core Curriculum Postgraduate Course: Obstructive sleep apnoea – current pathophysiological, clinical and therapeutic concepts Year: 2009 Cardiovascular morbidity and obstructive sleep apnoea in children Source: Annual Congress 2009 - Current developments in sleep-disordered breathing in children Year: 2009 Hypertension and obstructive sleep apnoea Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases Year: 2006 Cardiovascular and metabolic consequences of obstructive sleep apnoea Source: Eur Respir J 2001; 18: Suppl. 33, 519s Year: 2001 Comorbidities of obstructive sleep apnoea syndrome Source: Annual Congress 2011 - Comorbid obstructive sleep apnoea (OSA) and OSA comorbidities Year: 2011 Prevalence of complex sleep apnea among German patients with obstructive sleep apnea Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea Year: 2009 Albuminuria in children with obstructive sleep apnea Source: Annual Congress 2011 - Obstructive sleep apnoea: inflammation and metabolism Year: 2011 Cardiovascular regulation effects of CPAP therapy in obstructive sleep apnea patients with and without hypertension during daytime Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II Year: 2012 Pathophysiological consequences of obstructive sleep apnoea Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases Year: 2006 Predictors of long-term PAP-adherence in obstructive sleep apnea syndrome Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health Year: 2012 Daytime hypercapnia in patients with obstructive sleep apnoea syndrome (OSAS) Source: Eur Respir J 2002; 20: Suppl. 38, 493s Year: 2002 Unrecognised obstructive sleep apnoea is common in severe peripheral arterial disease Source: Eur Respir J 2013; 41: 616-620 Year: 2013 Obstructive pulmonary disorder is a potential risk factor of cardiovascular diseases in obstructive sleep apnea Source: Annual Congress 2008 - Control of breathing and respiratory disorders during sleep Year: 2008 Chronic respiratory failure in patients with obstructive sleep apnea (OSA) Source: Eur Respir J 2005; 26: Suppl. 49, 569s Year: 2005